10月15日 - ** 远程医疗公司Hims and Hers Health HIMS.N股价盘前上涨3.2%至55.75美元
** 公司称已推出妇女健康新专科，提供专为围绝经期和更年期妇女制定的负担得起的治疗计划
** 新产品将允许妇女向有执照的医疗服务提供者咨询，并获得根据其健康史和偏好量身定制的处方疗法
** 治疗可能包括丸剂、贴剂或膏剂形式的雌二醇和黄体酮--HIMS
** Hims & Hers 目前为 50 多万用户提供服务，年收入有望在 2026 年突破 10 亿美元。
** 截至上一交易日收盘，股价年内上涨了一倍多
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.